Care Home Development Finance: A Complete UK Guide

Care home development has become one of the most sought-after asset classes among specialist development finance lenders in the UK, and the fundamental reasons are demographic. The Office for National Statistics projects that the number of people aged 85 and over in England will double from 1.7 million in 2024 to 3.4 million by 2045. This structural demand underpins the investment case for new care home beds in a way that few other property sectors can match. Unlike speculative residential development, where demand can fluctuate with market sentiment and mortgage availability, the need for care beds is driven by an ageing population that is growing year on year regardless of economic conditions.

Lenders view care home developments favourably because they produce a secure, income-generating asset upon completion. Unlike a residential scheme where the developer must sell individual units to repay the loan, a completed care home generates recurring revenue from day one of operation. This revenue visibility allows lenders to model exit strategies with greater confidence. A 60-bed care home charging an average of £1,200 per week per bed at 90% occupancy generates annual gross revenue of approximately £3.37 million. Even at conservative margins, this income stream supports refinancing onto long-term investment debt, providing a clear and predictable exit route for the development lender.

Our lending panel includes several specialist healthcare lenders who actively seek care home opportunities. These lenders understand the sector-specific nuances that mainstream banks often struggle with, including the regulatory framework, the importance of operator quality, and the longer build-out periods typical of care home construction. We have arranged care home development facilities ranging from £2 million for 30-bed conversions to over £18 million for purpose-built 80-bed schemes. If you are considering a care home development, submit your project through our deal room for an initial assessment against our specialist panel.

The Care Quality Commission (CQC) is the independent regulator of health and social care services in England, and any care home development must be designed and operated in compliance with CQC standards. From a development finance perspective, CQC registration is not merely a regulatory hoop to jump through; it is a fundamental prerequisite that lenders will verify before advancing funds. A development that cannot achieve CQC registration has no operational value, and lenders will not fund a scheme without confidence that registration is attainable.

CQC registration requires a nominated individual (typically the registered manager) who is responsible for the regulated activity. The CQC assesses five key domains: safety, effectiveness, caring, responsiveness, and well-led. For new-build care homes, the CQC will review the design specifications against their guidance on minimum room sizes (typically 12 square metres for single rooms), corridor widths, communal space ratios, and accessibility standards. Lenders familiar with the sector will expect your architect to demonstrate that the floor plan meets or exceeds these requirements as part of the due diligence process.

Beyond the physical build, CQC registration requires detailed policies and procedures covering safeguarding, medication management, infection control, staffing levels, and complaints handling. Lenders do not typically review these operational documents themselves, but they will want to see evidence that you have engaged an experienced care home operator or management company who will be responsible for obtaining and maintaining registration. The distinction between the property developer and the care operator is critical, and most lenders prefer to see a clear separation between these roles.

In Scotland, the equivalent regulator is the Care Inspectorate, while in Wales it is Care Inspectorate Wales (CIW). Each jurisdiction has its own registration requirements and design standards. If you are developing a care home outside England, we will connect you with lenders who have specific experience in the relevant regulatory framework. Our guide on building regulations and development finance covers the broader regulatory landscape that applies to all development types.

Care home development finance deals are structured differently from standard residential schemes, reflecting the unique economics and risk profile of the sector. The most common structure involves senior debt at 55-65% of Gross Development Value (GDV), with the developer contributing 25-35% equity and, where required, mezzanine finance filling the gap. GDV for care homes is assessed on an operational basis, meaning the valuation reflects the income-generating potential of the completed facility rather than simply the cost of construction plus a developer's margin.

A typical new-build care home deal might look as follows: a 70-bed purpose-built care home with total development costs of £7.5 million (comprising £1.2 million land, £5.5 million construction, and £800,000 professional fees, contingency, and finance costs). The GDV, assessed on an EBITDA multiple basis assuming mature occupancy, might be £9.8 million. A senior lender at 60% LTGDV would provide a facility of £5.88 million, leaving the developer to fund the remaining £1.62 million from equity or mezzanine sources.

One critical difference from residential development is the stabilisation period. A completed care home does not generate maximum revenue immediately; it takes 18-30 months to reach mature occupancy of 85-90%. Development lenders must factor this ramp-up period into their exit strategy. Some specialist lenders offer a development-to-investment facility that seamlessly transitions from the construction phase into a longer-term loan secured against the operational income, avoiding the need for a separate refinancing at completion. This structure can save developers significant costs in legal and arrangement fees.

Rates for care home development finance typically carry a premium of 100-200 basis points over standard residential development loans, reflecting the longer exit timeline and the operational risk inherent in the sector. A developer who would secure 7.5% on a residential scheme should expect to pay 8.5-9.5% on a comparable care home project. However, the higher GDV multiples achievable on care homes often more than compensate for this additional cost.

The quality and credibility of the care home operator is arguably the single most important factor in a lender's credit decision on a care home development. Unlike residential development, where the exit is achieved through unit sales, a care home's value is entirely dependent on its operational performance. A beautifully constructed 70-bed care home with an incompetent operator is worth substantially less than a mediocre building run by an experienced, CQC-compliant operator. Lenders know this, and they will scrutinise the operator appointment as rigorously as they review the construction programme.

There are broadly three operating models that lenders encounter. The first is the developer-operator model, where the developer intends to operate the care home themselves or through a connected company. This model requires the developer to demonstrate significant operational experience, including a track record of CQC-rated services (ideally rated Good or Outstanding). Lenders are cautious about developers who claim they will learn the operational side as they go. The second model involves appointing a third-party operator under a management agreement, where the operator runs the home on behalf of the property owner for a management fee (typically 5-8% of gross revenue). The third model is a lease arrangement, where the completed care home is let to an operator on a long-term lease (typically 25-35 years) at an agreed rent.

From a lending perspective, the lease model provides the most predictable exit because the rental income is contractually fixed and the property's investment value can be readily assessed by multiplying the rent by an appropriate yield. A 70-bed care home let at £350,000 per annum to a reputable operator on a 30-year lease, capitalised at a 5.5% yield, has an investment value of approximately £6.36 million. The management agreement model is more complex because the income depends on the operator's performance, and the property's value fluctuates with occupancy and fee levels. Most mainstream development lenders prefer the lease model for its simplicity and certainty.

We always recommend that developers secure an operator agreement in principle before approaching lenders. A letter of intent or heads of terms from a credible operator, such as HC-One, Barchester Healthcare, Care UK, or a well-established regional group, significantly strengthens the funding application. Lenders will typically ask for the operator's most recent accounts, their CQC ratings across their existing portfolio, and their expansion strategy to assess whether the proposed home fits their operational capabilities.

Care homes in England fall within Use Class C2 (residential institutions) under the Town and Country Planning (Use Classes) Order 1987 (as amended). This classification is distinct from C3 (dwellinghouses) and has important planning implications. Local authorities generally view C2 applications favourably because they address a recognised demographic need, but the planning process for care homes involves specific considerations around highways impact, amenity space, and design standards that differ from residential schemes.

One significant advantage of C2 classification is that care homes are frequently exempt from affordable housing contributions under Section 106 agreements. Many local planning authorities only require affordable housing contributions on C3 residential developments. This exemption can represent a substantial financial benefit on a large care home scheme. On a development where a residential scheme would trigger a 35% affordable housing requirement, the equivalent care home might avoid this obligation entirely, although some authorities are beginning to challenge this position.

Care homes also have specific requirements around parking provision, outdoor amenity space, and accessibility. Most planning authorities will expect a care home to provide parking for staff and visitors rather than residents, and the ratio is typically lower than for residential development. A 70-bed care home might require 35-45 parking spaces, compared with 70-100 spaces if the same site were developed for 70 residential flats. However, highways officers will scrutinise shift-change traffic patterns and the adequacy of drop-off and ambulance access.

For developers considering converting an existing building into a care home, permitted development rights under Class M or Class MA do not apply to C2 uses. A full planning application is required for any change of use to a care home. This means that conversion projects, such as turning a former hotel or office building into a care home, require the same level of planning due diligence as a new-build scheme. We discuss the broader planning requirements for development finance applications in our guide on planning permission and development finance.

Developers transitioning from residential schemes to care home projects are often surprised by the pricing differential. Care home development finance is typically 100-200 basis points more expensive than equivalent residential finance, and the reasons are structural rather than arbitrary. Understanding why these premiums exist is important for appraising care home projects accurately and avoiding the mistake of applying residential finance assumptions to a fundamentally different asset class.

The primary driver of the pricing premium is exit risk. A residential development has a relatively straightforward exit: sell the completed units. Each unit sale reduces the loan balance, and the lender can model sales velocity based on comparable evidence. A care home, by contrast, is a single operational asset that cannot be disaggregated. The exit is either a refinancing onto investment debt or a sale of the entire facility as a going concern. Both routes depend on the care home being successfully operational, which introduces a layer of risk that does not exist in residential development. A care home that fails to achieve CQC registration, or receives a poor rating, could be worth significantly less than its construction cost.

The second factor is asset specificity. A half-built care home is significantly harder to repurpose than a half-built block of flats. If a residential developer defaults mid-build, the lender can appoint an administrator to complete the units and sell them on the open market. If a care home developer defaults, the lender faces a more complex recovery process because the building is designed for a specific use that requires an operator, staff, and regulatory approval. This reduced liquidity commands a premium in the lender's pricing model.

Despite the higher financing costs, care home developments frequently generate superior returns to residential projects. The GDV per square foot for a well-located care home, assessed on an operational basis, regularly exceeds the equivalent residential value. A care home development costing £7 million to build and achieving a GDV of £10 million delivers a 30% margin before finance costs, compared with a typical residential target of 20-22%. The higher finance cost is therefore offset by the higher absolute and relative profitability of the sector. For a broader comparison of how different finance types compare, see our guide on refurbishment finance versus development finance.

Applying for care home development finance requires a more comprehensive package than a standard residential application. In addition to the usual requirements of a detailed development appraisal, planning consent, and construction programme, lenders will expect to see a full operational business plan covering the first three to five years of trading. This business plan should include projected fee income by funding type (self-funded, local authority-funded, NHS-funded), staffing costs modelled at CQC-compliant ratios, and a realistic occupancy ramp-up schedule.

The development appraisal itself must be prepared on a dual basis. The first appraisal should show the traditional development finance metrics: total costs, GDV, LTGDV, developer's profit margin. The second should present the care home as an investment, showing the projected EBITDA at mature occupancy, the appropriate capitalisation rate, and the resulting investment value. Most specialist lenders will want both perspectives to satisfy their credit committee that the development is viable on construction metrics and sustainable as an operational business.

We recommend engaging a specialist healthcare property valuer, such as Christie & Co, Knight Frank Healthcare, or Savills Healthcare, to provide the RICS Red Book valuation. These valuers understand the operational valuation methodology and have access to comparable transactional evidence that generalist valuers lack. A valuation from a recognised healthcare specialist carries significantly more weight with lenders than one from a general practice surveyor. For more on the valuation process, refer to our guide on RICS Red Book valuations.

To start the process, submit your care home project through our deal room. Our team will review the scheme against our specialist healthcare lending panel and provide an indicative funding structure within 48 hours. We handle care home applications from initial enquiry through to completion, ensuring that the operational business plan and development appraisal are presented in the format that specialist lenders require.